Abstract
Many factors increasing the risks of developing psychosis have been identified. However, it is not known whether specific factors are linked to specific clinical profiles and outcomes, and whether the number of factors affecting the same patient correlates with their clinical profile, outcomes and treatment needs. The present study aimed to document the prevalence of risk factors and assess their clinical and outcome correlates in the early phases of psychosis. We used data from 269 patients in the prospective cohort of the Treatment and early Intervention in Psychosis Programme (TIPP), which offers 3 years of specialised treatment to young patients with first-episode psychosis. Relationships between risk factors (e.g., family history of schizophrenia or psychiatric illness, personal psychiatric history, migration in adversity, cannabis use, tobacco use, exposure to trauma), clinical presentation and various dimensions of outcome were assessed. The most common risk factors in this cohort of early psychosis patients were a family history of psychiatric illness (64.0%), a personal history of previous psychiatric disorders (53.6%), tobacco use (44.1%) and cannabis use (39.2%). Although some risk factors (e.g., family history of schizophrenia, personal psychiatric history) had no impact on the outcomes selected, others (e.g., migration in adversity, cannabis use, tobacco use and trauma) were associated with poorer symptomatic and functional outcomes. Results suggest that factors inducing an increased risk of developing psychosis also affect clinical presentation and outcome. Those risks should, therefore, be assessed at baseline and considered when defining treatment strategies.